Notice of Early Expiration of "Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies", NOT-AI-21-032
Notice Number:
NOT-AI-24-026
Key Dates
Related Announcements
- March 20, 2024 - Notice of Special Interest (NOSI) Inborn Errors of Immunity/Primary Immunodeficiencies. See Notice NOT-AI-24-024.
- March 29, 2024 - Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity", NOT-AI-21-082. See Notice NOT-AI-24-027.
- December 1, 2022 - Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies. See NOT-AI-21-032
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
Purpose
The purpose of this Notice is to inform the extramural community that NOT-AI-21-032, Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies will be expired as of March 20, 2024
Applicants are encouraged to consider applying to NOT-AI-24-024 – Notice of Special Interest (NOSI) Inborn Errors of Immunity/Primary Immunodeficiencies.
Inquiries
Please direct all inquiries to:
Maggie A. Morris Fears, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-761-5444
Email: [email protected]